-
-
-
-
-
-
-
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4
-
-
-
-
-
-
-
InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Files PCT Patent Application for Treating Neurodegenerative Disease Using a Rare Cannabinoid
-
-
-
-
-
-
-
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
-
1,201,763 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


